ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Anil Potti Joins Myrtle Beach Private Practice.

June 3, 2011

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

TGen At Scottsdale Opens Clinical Trial Of OSI-906 For Adrenocortical Carcinoma

September 25, 2009

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

September 7, 1990

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012